ACTIONABILITY KNOWLEDGE REPOSITORY ACTIONABILITY CURATION INTERFACE
Update History
Condition: von Willebrand Disease
Gene/Gene Panel: VWF
Context: Adult
Date
Status
Release
Outcomes-Interventions
Notes
2020/04/16
Released (Under revision)
1.1.1
A
Bleeding complications (GroupA)
Anti-hemorrhagic interventions in trauma settings (GroupA) 10CA
Pharmacological intervention for scheduled procedures (GroupA) 10CA
Bleeding complications (GroupB)
Anti-hemorrhagic interventions in trauma settings (GroupB) 10CA
Pharmacological intervention for scheduled procedures (GroupB) 10CA
Clinically significant bleeding (GroupA)
Pharmacological prophylaxis (GroupA) 6CB
Clinically significant bleeding (GroupB)
Pharmacological prophylaxis (GroupB) 9CB
added MONDO IDs and created scoring groups
2020/04/08
Released
1.1.1
A
Bleeding complications (GroupA)
Anti-hemorrhagic interventions in trauma settings (GroupA) 10CA
Pharmacological intervention for scheduled procedures (GroupA) 10CA
Bleeding complications (GroupB)
Anti-hemorrhagic interventions in trauma settings (GroupB) 10CA
Pharmacological intervention for scheduled procedures (GroupB) 10CA
Clinically significant bleeding (GroupA)
Pharmacological prophylaxis (GroupA) 6CB
Clinically significant bleeding (GroupB)
Pharmacological prophylaxis (GroupB) 9CB
added MONDO IDs and created scoring groups
2019/10/03
Released (Under revision)
1.1.0
A
Bleeding complications (Type 3)
Anti-hemorrhagic interventions in trauma settings (Type 3) 10CA
Pharmacological intervention for scheduled procedures (Type 3) 10CA
Bleeding complications (Types 1 and 2)
Anti-hemorrhagic interventions in trauma settings (Types 1 and 2) 10CA
Pharmacological intervention for scheduled procedures (Types 1 and 2) 10CA
Clinically significant bleeding (Type 3)
Pharmacological prophylaxis (Type 3) 9CB
Clinically significant bleeding (Types 1 and 2)
Pharmacological prophylaxis (Types 1 and 2) 6CB
Internal system migration related to merging adult and pediatric contexts.
2019/04/04
Released
1.1.0
A
Bleeding complications (Type 3)
Anti-hemorrhagic interventions in trauma settings (Type 3) 10CA
Pharmacological intervention for scheduled procedures (Type 3) 10CA
Bleeding complications (Types 1 and 2)
Anti-hemorrhagic interventions in trauma settings (Types 1 and 2) 10CA
Pharmacological intervention for scheduled procedures (Types 1 and 2) 10CA
Clinically significant bleeding (Type 3)
Pharmacological prophylaxis (Type 3) 9CB
Clinically significant bleeding (Types 1 and 2)
Pharmacological prophylaxis (Types 1 and 2) 6CB
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.0.3
A
Bleeding complications (Type 3)
Anti-hemorrhagic interventions in trauma settings (Type 3) 10CA
Pharmacological intervention for scheduled procedures (Type 3) 10CA
Bleeding complications (Types 1 and 2)
Anti-hemorrhagic interventions in trauma settings (Types 1 and 2) 10CA
Pharmacological intervention for scheduled procedures (Types 1 and 2) 10CA
Clinically significant bleeding (Type 3)
Pharmacological prophylaxis (Type 3) 9CB
Clinically significant bleeding (Types 1 and 2)
Pharmacological prophylaxis (Types 1 and 2) 6CB
Internal system migration related to score text replacement from E to N
2018/07/24
Released
1.0.2
A
Bleeding complications (Type 3)
Anti-hemorrhagic interventions in trauma settings (Type 3) 10CA
Pharmacological intervention for scheduled procedures (Type 3) 10CA
Bleeding complications (Types 1 and 2)
Anti-hemorrhagic interventions in trauma settings (Types 1 and 2) 10CA
Pharmacological intervention for scheduled procedures (Types 1 and 2) 10CA
Clinically significant bleeding (Type 3)
Pharmacological prophylaxis (Type 3) 9CB
Clinically significant bleeding (Types 1 and 2)
Pharmacological prophylaxis (Types 1 and 2) 6CB
2018/07/24
Released (Under revision)
1.0.1
A
Bleeding complications (Type 3)
Anti-hemorrhagic interventions in trauma settings (Type 3) 10CA
Pharmacological intervention for scheduled procedures (Type 3) 10CA
Bleeding complications (Types 1 and 2)
Anti-hemorrhagic interventions in trauma settings (Types 1 and 2) 10CA
Pharmacological intervention for scheduled procedures (Types 1 and 2) 10CA
Clinically significant bleeding (Type 3)
Pharmacological prophylaxis (Type 3) 9CB
Clinically significant bleeding (Types 1 and 2)
Pharmacological prophylaxis (Types 1 and 2) 6CB
2018/07/24
Released
1.0.1
A
Bleeding complications (Type 3)
Anti-hemorrhagic interventions in trauma settings (Type 3) 10CA
Pharmacological intervention for scheduled procedures (Type 3) 10CA
Bleeding complications (Types 1 and 2)
Anti-hemorrhagic interventions in trauma settings (Types 1 and 2) 10CA
Pharmacological intervention for scheduled procedures (Types 1 and 2) 10CA
Clinically significant bleeding (Type 3)
Pharmacological prophylaxis (Type 3) 9CB
Clinically significant bleeding (Types 1 and 2)
Pharmacological prophylaxis (Types 1 and 2) 6CB
2018/07/24
Released (Under revision)
1.0.0
A
Bleeding complications (Type 3)
Anti-hemorrhagic interventions in trauma settings (Type 3) 10CA
Pharmacological intervention for scheduled procedures (Type 3) 10CA
Bleeding complications (Types 1 and 2)
Anti-hemorrhagic interventions in trauma settings (Types 1 and 2) 10CA
Pharmacological intervention for scheduled procedures (Types 1 and 2) 10CA
Clinically significant bleeding (Type 3)
Pharmacological prophylaxis (Type 3) 9CB
Clinically significant bleeding (Types 1 and 2)
Pharmacological prophylaxis (Types 1 and 2) 6CB
2017/12/07
Released
1.0.0
A
Bleeding complications (Type 3)
Anti-hemorrhagic interventions in trauma settings (Type 3) 10CA
Pharmacological intervention for scheduled procedures (Type 3) 10CA
Bleeding complications (Types 1 and 2)
Anti-hemorrhagic interventions in trauma settings (Types 1 and 2) 10CA
Pharmacological intervention for scheduled procedures (Types 1 and 2) 10CA
Clinically significant bleeding (Type 3)
Pharmacological prophylaxis (Type 3) 9CB
Clinically significant bleeding (Types 1 and 2)
Pharmacological prophylaxis (Types 1 and 2) 6CB
¤ Powered by BCM's Genboree.